Skip to NavigationSkip to content

News

Pfizer has revealed that it has shut down a trial of Inlyta after it failed to improve disease-free survival as an adjuvant therapy in the...
Alexion Pharmaceuticals is badly in need of alternative revenue streams to Soliris, its mega-blockbuster that could start to face competition in a...
Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, first looking at a Botox...
Theresa May has revealed that a further £75 million will be made available for research into the illness, as well as money being allocated to help...
MSD has announced that its blockbuster immunotherapy drug Keytruda hit its primary endpoint as a monotherapy in the first-line treatment of locally...
Nuplazid is Acadia Pharmaceuticals' treatment for those with Parkinson's disease suffering from hallucinations and delusions, it's the only treatment...
A new study has revealed a link between antiepileptic drug use and an increased risk of developing Alzheimer’s disease and dementia.
Immunomedics hasn’t had the most straight forward year but it's now trying to achieve some stability by bringing a fresh face into its C-suite, after...
A report conducted by charity Orchid has revealed a “worrying trend” in the treatment of prostate cancer, indicating that as many as four in ten...
Facebook can’t catch a break at the moment, after being widely criticised for its practices over the security of users’ data, it is back in the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches